スピーカー
Koji Eto, MD, PhD
Professor, Department of Clinical Application, Kyoto University, Japan
Kohnosuke Mitani, PhD
Professor, Division of Gene Therapy and Genome Editing, Saitama Medical University, Japan
Hiroshi Shiku, MD, PhD
Professor, Mie University Graduate School of Medicine, Japan
Wilson W. Bryan, MD
Executive Vice President, Drug and Biological Products, Greenleaf Health, United States
Wilson Bryan is a neurologist who graduated from the University of Chicago Pritzker School of Medicine. Dr. Bryan served on the neurology faculty of the University of Texas Southwestern Medical School for 13 years. He has been an investigator on clinical trials in cerebrovascular disease and neuromuscular disorders, particularly amyotrophic lateral sclerosis. Dr. Bryan joined the United States Food and Drug Administration (FDA) in 2000. From 2016 until his recent retirement, he served as Director of the Office of Tissues and Advanced Therapies (OTAT) in the Center for Biologics Evaluation and Research (CBER).